vTv Therapeutics GAAP EPS of -$1.08 misses by $0.11

* vTv Therapeutics press release [https://seekingalpha.com/pr/20298026-vtv-therapeutics-reports-third-quarter-2025-financial-results-and-provides-corporate-update] (VTVT [https://seekingalpha.com/symbol/VTVT]): Q3 GAAP EPS of -$1.08 misses by $0.11.
* The Company’s cash position as of September 30, 2025, was $98.5 million compared to $36.7 million as of December 31, 2024.

MORE ON VTV THERAPEUTICS

* vTv Therapeutics registers 15.9M Class A shares for potential resale [https://seekingalpha.com/news/4501796-vtv-therapeutics-registers-159m-class-a-shares-for-potential-resale]
* vTv Therapeutics announces $80M PIPE financing; shares up 14% [https://seekingalpha.com/news/4491147-vtv-therapeutics-announces-80m-pipe-financing-shares-up-14]
* Seeking Alpha’s Quant Rating on vTv Therapeutics [https://seekingalpha.com/symbol/VTVT/ratings/quant-ratings]
* Historical earnings data for vTv Therapeutics [https://seekingalpha.com/symbol/VTVT/earnings]
* Financial information for vTv Therapeutics [https://seekingalpha.com/symbol/VTVT/income-statement]